Dosage of Sacituzumab govitecan
Sacituzumab govitecan is an injectable drug in a single-dose vial with a recommended dose of 10 mg/kg administered as a weekly intravenous infusion on days 1 and 8 of a 21-day treatment cycle. Continue treatment until disease progression or unacceptable toxicity. Do not give patients gosatuzumab at doses greater than 10 mg/kg. Gosatuzumab is currently only available as an intravenous infusion and should not be administered as an intravenous push or push injection.

Before each patient takes gosatuzumab, it is recommended to take preoperative medication to prevent infusion reactions and chemotherapy-induced nausea and vomiting (CINV). Patients with past infusion reactions can be treated medically with antipyretics, H1 and H2 blockers, and corticosteroids before infusion. Pretreat with a two- or three-drug combination regimen (eg, dexamethasone with a 5-HT3 receptor antagonist or an NK1 receptor antagonist, and other drugs as indicated). The patient's first infusion should take more than 3 hours, and patients should be observed for signs or symptoms of infusion-related reactions during the infusion and for at least 30 minutes after the initial dose; if tolerated by the previous infusion, infuse gosatuzumab within 1 to 2 hours. Observe the patient during the infusion and for at least 30 minutes after the infusion.
Gosatuzumab The original drug has been launched in China, but it has not yet been included in the medical insurance. The price of a 100mg bottle may be around 10,000 yuan, which is relatively expensive. Gosatuzumab Original drug marketed overseas has three versions: European version, American version, and Singapore version. SpecificationsThe price of each 100 mg bottle may be around RMB 10,000-35,000 (the price may fluctuate due to exchange rates). The ingredients of gosatuzumab sold domestically and abroad are basically the same. There is currently no generic version of gosatuzumab available on the market. For specific prices and drug information, please consult your medical consultant.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)